Recro Pharma files for $100M mixed shelf and equity from existing investors

|About: Recro Pharma, Inc. (REPH)|By:, SA News Editor

Recro Pharma (NASDAQ:REPH) has filed a prospectus for a $100M mixed shelf offering and 348,664 warrants and 348,664 common shares from current stockholders.

Subscribe for full text news in your inbox